The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Studies have found important benefits from the new RSV immunization and enhanced versions of the flu shot. Plus, the shingles ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

As the Trump administration’s FDA moves to limit approval for COVID-19 booster shots, millions of Americans under 65 may find themselves without access this fall. However, until Friday, there ...

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the ...

People 65 years and older will benefit from getting a flu shot, but they should never get a nasal spray vaccine. There are two vaccines designed specifically for this group: High Dose Flu Vaccine.

COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants ...

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults.

The new vaccine showed a 9.3% higher relative vaccine efficacy than the mRNA-1273 in individuals aged 12 years and older. It was 13.5% better in adults aged 65 and older.

At the time of this writing, a new strain (NB.1.8.1) is rapidly spreading in other countries and in North America.

The FDA will prioritize approval of COVID-19 vaccines which can be proven to generate antibody titers in people over age 65 or people who are 6 months or older and at high risk for severe disease ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company said Saturday, the first approval under new regulations.